Müller Glial‐Derived Small Extracellular Vesicles Mitigate RGC Degeneration by Suppressing Microglial Activation via Cx3cl1‐Cx3cr1 Signaling
Advanced Healthcare Materials · 2025-05 · 14 (12)
DOI: 10.1002/adhm.202404306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 25.03.2025. Verfasst von Hai-Dong Qian und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, China. Hauptthemen laut MEDLINE: CX3C Chemokine Receptor 1, Chemokine CX3CL1, Extracellular Vesicles, Microglia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Retinal ganglion cell (RGC) degeneration leads to irreversible blindness. Müller glia (MG) play pivotal roles in retinal homeostasis and disease through paracrine signaling. Small extracellular vesicles (sEVs) are bioactive nanomaterials derived from all types of live cells and are recognized as a potential strategy for neuroprotective therapy. The aim of this study is to investigate the potential roles of MG‐derived sEVs (MG‐sEVs) in a mouse model of optic nerve injury (ONC). It is found that MG‐sEVs treatment effectively mitigates RGC degeneration and suppresses microglial activation, thereby improves visual function in ONC mice. Retinal transcriptomic analysis reveals a strong correlation between C‐x3‐c motif chemokine ligand 1 (Cx3cl1)‐mediated glial activation and inflammation. Subsequently, it is confirmed that the expression levels of Cx3cl1 and proinflammatory cytokines are significantly decreased in retinas treated with MG‐sEVs. The components analysis of MG‐sEVs cargo identifies that miR‐125b‐5p and miR‐16‐5p target Cx3cl1 gene to regulate its expression. It is also observed that Cx3cl1 colocalizes on the microglia of transgenic C‐x3‐c motif chemokine receptor 1 (Cx3Cr1)‐GFP mice. In conclusion, MG‐sEVs mitigate RGC degeneration by suppressing microglial activation via Cx3cl1‐Cx3cr1 signaling. This research provides additional opportunities for the treatment of RGC degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
- National Clinical Research Center for Ocular Diseases, Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
ORCID-Profile: Tong Li, Zai-Long Chi
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Qian, H. D., Song, X. Y., He, G. W., Peng, X. N., Chen, Y., Huang, P., Zhang, J., Lin, X. Y., Gao, Q., Zhu, S. M., Li, T., & Chi, Z. L. (2025). Müller Glial‐Derived Small Extracellular Vesicles Mitigate RGC Degeneration by Suppressing Microglial Activation via Cx3cl1‐Cx3cr1 Signaling. Advanced Healthcare Materials, 14(12). https://doi.org/10.1002/adhm.202404306
Vancouver
Qian HD, Song XY, He GW, Peng XN, Chen Y, Huang P, et al. Müller Glial‐Derived Small Extracellular Vesicles Mitigate RGC Degeneration by Suppressing Microglial Activation via Cx3cl1‐Cx3cr1 Signaling. Advanced Healthcare Materials. 2025;14(12). doi:10.1002/adhm.202404306
BibTeX
@article{Qian2025,
author = {Qian, Hai-Dong and Song, Xiang-Yuan and He, Guan-Wen and Peng, Xue-Ni and Chen, Ying and Huang, Pan and Zhang, Jing and Lin, Xiao-Yan and Gao, Qiao and Zhu, Sen-Miao and Li, Tong and Chi, Zai-Long},
title = {Müller Glial‐Derived Small Extracellular Vesicles Mitigate RGC Degeneration by Suppressing Microglial Activation via Cx3cl1‐Cx3cr1 Signaling},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {12},
doi = {10.1002/adhm.202404306}
}
EUVIMED